Is Gilead Sciences Worth the Wait?

New Gilead Sciences (NASDAQ: GILD) CEO Daniel O'Day sat down for questions at the Jefferies Healthcare Conference on Wednesday. He repeated one word multiple times in his comments. That word was "later."